Huons Co., Ltd. (243070.KQ)

KRW 28400.0

(1.79%)

Operating Income Summary of Huons Co., Ltd.

Huons Co., Ltd.'s latest annual operating income in 2023 was 59.79 Billion KRW , up 39.76% from previous year.
Huons Co., Ltd.'s latest quarterly operating income in 2024 Q1 was 10.65 Billion KRW , down -7.23% from previous quarter.
Huons Co., Ltd. reported an annual operating income of 39.46 Billion KRW in 2022, down -11.19% from previous year.
Huons Co., Ltd. reported an annual operating income of 44.43 Billion KRW in 2021, down -17.89% from previous year.
Huons Co., Ltd. reported a quarterly operating income of 9.3 Billion KRW for 2024 Q2, down -12.62% from previous quarter.
Huons Co., Ltd. reported a quarterly operating income of 17.81 Billion KRW for 2023 Q2, up 59.43% from previous quarter.

Annual Operating Income Chart of Huons Co., Ltd. (2023 - 2014)

Historical Annual Operating Income of Huons Co., Ltd. (2023 - 2014)

Year	Operating Income	Operating Income Growth
2023	59.79 Billion KRW	39.76%
2022	39.46 Billion KRW	-11.19%
2021	44.43 Billion KRW	-17.89%
2020	54.12 Billion KRW	11.85%
2019	48.39 Billion KRW	6.86%
2018	45.28 Billion KRW	25.03%
2017	36.21 Billion KRW	68.24%
2016	21.52 Billion KRW	0.0%
2014	30.09 Billion KRW	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	10.65 Billion KRW	-7.23%
2024 Q2	9.3 Billion KRW	-12.62%
2023 Q2	17.81 Billion KRW	59.43%
2023 FY	55.15 Billion KRW	39.76%
2023 Q4	11.48 Billion KRW	-21.78%
2023 Q1	11.17 Billion KRW	-28.2%
2023 Q3	14.68 Billion KRW	-17.59%
2022 Q2	10.63 Billion KRW	-9.22%
2022 Q4	15.56 Billion KRW	668.6%
2022 Q3	2.02 Billion KRW	-80.97%
2022 Q1	11.71 Billion KRW	209.43%
2022 FY	39.46 Billion KRW	-11.19%
2021 Q2	12.56 Billion KRW	-7.78%
2021 FY	44.43 Billion KRW	-17.89%
2021 Q1	13.62 Billion KRW	-3.8%
2021 Q4	3.78 Billion KRW	-73.89%
2021 Q3	14.5 Billion KRW	15.48%
2020 Q3	15.33 Billion KRW	15.72%
2020 Q1	11.38 Billion KRW	-16.71%
2020 Q2	13.24 Billion KRW	16.34%
2020 FY	54.12 Billion KRW	11.85%
2020 Q4	14.15 Billion KRW	-7.63%
2019 Q2	8.72 Billion KRW	-27.57%
2019 FY	48.39 Billion KRW	6.86%
2019 Q4	13.67 Billion KRW	-2.0%
2019 Q3	13.95 Billion KRW	59.9%
2019 Q1	12.04 Billion KRW	54.0%
2018 FY	45.28 Billion KRW	25.03%
2018 Q2	12.2 Billion KRW	5.77%
2018 Q3	13.72 Billion KRW	12.52%
2018 Q1	11.53 Billion KRW	29.89%
2018 Q4	7.82 Billion KRW	-43.03%
2017 Q1	7.13 Billion KRW	-59.48%
2017 FY	36.21 Billion KRW	68.24%
2017 Q4	8.88 Billion KRW	-22.49%
2017 Q3	11.45 Billion KRW	31.08%
2017 Q2	8.74 Billion KRW	22.43%
2016 Q3	10.28 Billion KRW	0.0%
2016 FY	21.52 Billion KRW	0.0%
2016 Q4	17.62 Billion KRW	71.29%
2014 FY	30.09 Billion KRW	0.0%

Peer Operating Income Comparison of Huons Co., Ltd.

Name	Operating Income	Operating Income Difference
HLB Pharmaceutical Co., Ltd	-19.54 Billion KRW	405.976%
CMG Pharmaceutical Co., Ltd.	5.72 Billion KRW	-944.409%
Celltrion Pharm, Inc.	36.07 Billion KRW	-65.77%
Huons Global Co., Ltd.	122.92 Billion KRW	51.357%
DongKook Pharmaceutical Co., Ltd.	66.87 Billion KRW	10.585%
Enzychem Lifesciences Corporation	-14.35 Billion KRW	516.508%
Humedix Co., Ltd.	37.31 Billion KRW	-60.264%
Boditech Med Inc.	33.44 Billion KRW	-78.795%
EuBiologics Co., Ltd.	7.69 Billion KRW	-676.641%
FutureChem Co.,Ltd	-8.4 Billion KRW	811.17%
BNC Korea Co., Ltd.	10.81 Billion KRW	-452.696%
AptaBio Therapeutics Inc.	-16.37 Billion KRW	465.19%